Tritanium Primary Acetabular Shell Study
ClinicalTrials.gov NCT01063751
Research payments
$205,238
Through program year 2025, $205,238 in research payments was reported against Tritanium Primary Acetabular Shell Study, across 172 payments, paid by Stryker Corporation.
- Paid by
- Stryker Corporation
- ClinicalTrials.gov
- NCT01063751
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,880 | 1 |
| 2024 | Research | $10,808 | 13 |
| 2023 | Research | $42,407 | 24 |
| 2022 | Research | $22,021 | 22 |
| 2021 | Research | $22,296 | 22 |
| 2020 | Research | $48,746 | 56 |
| 2019 | Research | $56,081 | 34 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Timothy Izant De Witt, NY Named on 33 payments
- Brock Lindsey Morgantown, WV Named on 27 payments
- John Noble Lake Charles, LA Named on 20 payments
- John Diana Napa, CA Named on 17 payments
- David Newman Watertown, NY Named on 9 payments
- Carmen Crofoot Bangor, ME Named on 9 payments
- Daniel Delgaizo Chapel Hill, NC Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.